Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Sruthi Adimadhyam, Ph.D.

Concepts (115)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Dipeptidyl-Peptidase IV Inhibitors220192841.030 Why?
Product Surveillance, Postmarketing220214550.690 Why?
Mycoses120183710.530 Why?
Ipratropium12013170.480 Why?
Antifungal Agents120187240.480 Why?
Diabetic Angiopathies120188200.450 Why?
Diabetes Mellitus, Type 232019116540.380 Why?
Bronchodilator Agents120134990.360 Why?
Drug Prescriptions1201816340.340 Why?
Fractures, Bone1201919250.310 Why?
Renal Insufficiency, Chronic1202021990.280 Why?
Antirheumatic Agents3202013210.250 Why?
Propensity Score3202117530.240 Why?
Arrhythmias, Cardiac1201322550.230 Why?
United States Food and Drug Administration2202115850.220 Why?
Lymphoma, Non-Hodgkin2201813780.190 Why?
Hydrochlorothiazide12021980.190 Why?
Narcolepsy120231950.190 Why?
Lymphoma, Large B-Cell, Diffuse2201913750.170 Why?
Filgrastim120181310.170 Why?
Hematologic Agents12018390.170 Why?
Antihypertensive Agents2202120340.160 Why?
Tumor Necrosis Factor-alpha3202044200.160 Why?
Oseltamivir12018750.160 Why?
Photosensitizing Agents120216000.140 Why?
Carcinoma, Basal Cell120215460.130 Why?
Glucosides120184130.130 Why?
Asthma1201359240.130 Why?
Incidence42021208830.120 Why?
Neutropenia120188860.120 Why?
Polyethylene Glycols1201811840.110 Why?
Thromboembolism120199850.110 Why?
Risk Factors62021717840.110 Why?
Benzhydryl Compounds120188080.110 Why?
Electronic Prescribing120131220.110 Why?
Sex Factors32021103860.100 Why?
Biological Products120208430.100 Why?
Neoplasms, Second Primary1201810410.100 Why?
Rheumatic Diseases120175880.090 Why?
Crohn Disease1202222940.090 Why?
SEER Program3201915090.090 Why?
Antiviral Agents2202129460.090 Why?
Myelodysplastic Syndromes1201813560.080 Why?
Case-Control Studies52020216950.080 Why?
Attention Deficit Disorder with Hyperactivity1202335820.080 Why?
United States92023693620.080 Why?
Medical Order Entry Systems120135470.080 Why?
Proportional Hazards Models22021123370.080 Why?
Suicide1201814640.080 Why?
Documentation120138560.070 Why?
Medication Errors120137960.070 Why?
Retrospective Studies92022762000.070 Why?
Influenza, Human1201814840.070 Why?
Male1320213490250.070 Why?
Female1320213785100.070 Why?
Middle Aged820212131150.070 Why?
Medication Adherence1201720410.070 Why?
Carcinoma, Squamous Cell1202140240.060 Why?
Biomedical Research1202033010.060 Why?
Humans1820237369400.060 Why?
Dementia1201824620.060 Why?
Glioma1201933760.060 Why?
Healthcare Disparities1201931210.060 Why?
Salts12023660.060 Why?
Leukemia, Myeloid, Acute1201834740.060 Why?
Aged920211626790.050 Why?
Arthritis, Rheumatoid1201836580.050 Why?
Odds Ratio3202098600.050 Why?
Amphetamine120232220.050 Why?
Multiple Myeloma1202051220.050 Why?
Skin Neoplasms1202156250.050 Why?
Follow-Up Studies22019389370.050 Why?
Adult620212132830.050 Why?
Databases, Factual3202177110.050 Why?
Drugs, Generic120234180.040 Why?
Necrosis1202216500.040 Why?
Age Factors32021183590.040 Why?
Risk Assessment12018232980.040 Why?
Treatment Outcome22022625010.030 Why?
Granulocyte Colony-Stimulating Factor120186410.030 Why?
Ultraviolet Rays1202110560.030 Why?
Socioeconomic Factors2201977150.030 Why?
Cohort Studies12018402930.030 Why?
Insurance Claim Review120197250.030 Why?
Arthritis120206600.030 Why?
Communicable Disease Control120218460.030 Why?
Angiotensin-Converting Enzyme Inhibitors1202115020.030 Why?
Logistic Models22019134080.030 Why?
Aged, 80 and over42019577380.030 Why?
Immunotherapy2201943500.030 Why?
Hypertension1201383800.030 Why?
Information Storage and Retrieval120188240.030 Why?
Medication Systems, Hospital120131600.030 Why?
Adolescent32018852250.030 Why?
Cross-Over Studies1201820230.030 Why?
Medical Record Linkage120132830.030 Why?
Medicare2201964400.020 Why?
Young Adult22017562390.020 Why?
Interleukin-61202031940.020 Why?
Medicaid1202327010.020 Why?
Residence Characteristics1201920400.020 Why?
Child22018767000.020 Why?
Health Policy1202126590.020 Why?
Dose-Response Relationship, Drug12021109580.020 Why?
Venous Thromboembolism1201916630.020 Why?
Neoplasm Staging12019109680.020 Why?
Electronic Health Records1202144180.020 Why?
Decision Support Systems, Clinical1201311610.010 Why?
Neoplasm Recurrence, Local1201991290.010 Why?
Pandemics1202181680.010 Why?
Antineoplastic Combined Chemotherapy Protocols12018113950.010 Why?
Prognosis12018289670.010 Why?
Antineoplastic Agents12019136380.010 Why?
Infant12018348650.010 Why?
Child, Preschool12018407850.010 Why?
Adimadhyam's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (115)
Explore
_
Co-Authors (10)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.